Dendris Overview

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $856K

  • Investors
  • 2

Dendris General Information

Description

Developer of a biotechnological chip designed to perform syndromic diagnosis of infectious bacteria. The company's chip performs a syndromic test allowing the analysis of bacteria simultaneously based on the functionalization of the support by phosphorus dendrimers, enabling clinicians to diagnose causes of illness reliably and cost-effectively.

Contact Information

Website
www.dendris.fr
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 335 Rue Du Chene Vert
  • Zac De La Bourgade
  • 31670 Labege
  • France
+33 05
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
HealthTech
Corporate Office
  • 335 Rue Du Chene Vert
  • Zac De La Bourgade
  • 31670 Labege
  • France
+33 05

Dendris Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dendris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 06-Dec-2022 $856K Completed Startup
6. Angel (individual) 30-Jun-2021 Completed Startup
5. Angel (individual) 02-May-2019 Completed Startup
4. Angel (individual) 25-Jan-2018 Completed Startup
3. Angel (individual) 29-Apr-2016 Completed Startup
2. Angel (individual) 01-Jun-2015 $678K $678K Completed Startup
1. Accelerator/Incubator 07-Mar-2008 Completed Startup
To view Dendris’s complete valuation and funding history, request access »

Dendris Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B Shares
A Shares
B Shares
A Shares
Ordinary Shares
Ordinary Shares 2,399 $10.308272 $206.17 $206.17 1x $206.17 11%
Ordinary Shares 6,525 $10.308272 $172.15 $172.15 1x $172.15 29.92%
To view Dendris’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Dendris Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Dendris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3142558-A1 Solid support functionalized by dendrimers, biochip comprising such a solid support and use for the detection of a target molecule in a medium Pending 28-Nov-2022
US-20180311635-A1 Method for immobilising a compound of interest on a substrate in a given pattern and kit for implementing same Inactive 29-Oct-2014
FR-3028046-B1 Method of immobilizing a compound of interest on a support according to a designed pattern and kit for its implementation Inactive 29-Oct-2014
FR-3028046-A1 Method of immobilizing a compound of interest on a support according to a designed pattern and kit for its implementation Active 29-Oct-2014
CA-3000291-A1 Method for immobilising a compound of interest on a substrate in a given pattern and kit for implementing same Inactive 29-Oct-2014 B01J19/0046
To view Dendris’s complete patent history, request access »

Dendris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dendris Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capitole Angels Angel Group Minority
Nubbo Accelerator/Incubator
To view Dendris’s complete investors history, request access »

Ready to get started?

Request a free trial

Dendris FAQs

  • Where is Dendris headquartered?

    Dendris is headquartered in Labege, France.

  • What is the size of Dendris?

    Dendris has 7 total employees.

  • What industry is Dendris in?

    Dendris’s primary industry is Diagnostic Equipment.

  • Is Dendris a private or public company?

    Dendris is a Private company.

  • What is the current valuation of Dendris?

    The current valuation of Dendris is .

  • What is Dendris’s current revenue?

    The current revenue for Dendris is .

  • How much funding has Dendris raised over time?

    Dendris has raised $3.99M.

  • Who are Dendris’s investors?

    Capitole Angels and Nubbo have invested in Dendris.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »